Dr. Lucinda Grande

 Dr. Grande Portrait


BS in Computer Science Cum Laude, Boston University

MD, University of Washington School of Medicine

Board Certifications:

Family Medicine, American Board of Family Medicine

Addiction Medicine, American Board of Preventive Medicine


St. Peter Family Medicine in Olympia, Washington

Joined Pioneer Family Practice:


Medical Interests:

Chronic pain

Substance use disorder

Microdosing of ketamine for pain, depression and transition to buprenorphine from fentanyl

Creative approaches to challenging medical problems

Honors & awards

  • SIIA EXCEL Award for “Bending the Curve,” published in Washington State Medical Association’s WSMA Reports, Bronze in the Editorial/Opinion Piece category · 2023
  • Fellow, American Society of Addiction Medicine, Issued by American Society of Addiction Medicine · 2023
  • Grassroots Advocacy Award, Issued by Washington State Medical Association
  • Health Care Champions Award for Innovative Community Service, Issued by Thurston County Chamber of Commerce and Thurston Mason County Medical Society


Classical music, international travel, global health, spending time with her husband and two basset hounds and her grown son who lives in Thailand.


with Cundiff C, Murray M, Greenwald M, Wright T, Martin S
Journal of Addiction Medicine · Jun 16, 2023

Prescribing the Buprenorphine Monoproduct for Adverse Effects of Buprenorphine-Naloxone

Prim Care Companion CNS Disord · Mar 1, 2017
with Thompson EC, Au MA, Sawyer D, Baldwin LM, Rosenblatt, RA
J Am Board Fam Med · Nov 12, 2016

with Mendez RD, Krug RT, Verschuyl EJ
Lancet · Apr 4, 2009

Anesthesia and Analgesia · Oct 1, 2008

Education and advocacy activities:

  • 2011- present: University of Washington School of Medicine, Department of Family Medicine, Clinical Assistant Professor 2018-present, Clinical Instructor 2011-2017       
  • 2017-present: American Association of Public Health Physicians, Member, Resolutions, Policies and Legislation Committee
  • 2021-present: Washington Society of Addiction Medicine, Board Member at Large 2011-2023, Secretary/Treasurer 2023
  • 6/27/2023 UW Medicine Newsroom, Guidelines for opioid treatment drug ignore fentanyl surge
  • 4/2023: Ketamine-Assisted Buprenorphine Initiation, Presentation, Annual Meeting of the American Society of Addiction Medicine, with Tom Hutch, MD and Andrew Herring, MD
  • 2/2023: Ketamine Treatment Across the Dose Spectrum, Program Director, 6 hour continuing medical education course, with Rakesh Jain, MD, Steven Mandel, MD, David Dansky, MD, Lindsay Wilkinson, ND, and Hilary Sandell, ND
  • 2019-2022: Eliminating the Buprenorphine Waiver, Resolution approved by the Washington State Medical Association, adopted by American Medical Association, ultimately passed by Congress in 2022
  • 2/2020: Pew Charitable Trusts, Community Opioid Response and Evaluation grant to Olympia Bupe Clinic at Capital Recovery Center, in partnership with University of Washington Addictions, Drug and Alcohol Institute and St. Martin University
  • 6/10/2015: Northwest Public Radio
    In Time Of Need, A Treatment For Heroin Addiction Is Hard To Come By, by Rowan Moore-Gerety
  • 4/26/2015: The Olympian
    Lacey doctor seeks subjects for non-narcotic pain control study, by Jerre Redecker
  • 11/22/2014: Seattle Times
    As heroin fatalities rise, some see hope in “bupe”, by Sandi Doughton